Rediscover Microbiology

Rediscover
Microorganisms

Precise health, starting from the intestine

In the known biotech blue ocean
Explore the unknown shore of knowledge

Expanding our horizons, discovering new insights,
and forging a healthier future through the power of microorganisms.
Expanding our horizons, discovering new insights, and forging a healthier future through the power of microorganisms.

Rediscover Microbiology

Leeuwenhoek was founded in August 2011 as a start-up company derived from the technology transfer of National Taiwan University.
We focus on providing microbial polysomics technology services and are committed to developing innovative services and products that promote metabolic health through intestinal flora regulation.
We are scientifically research-based and are committed to expanding innovative applications of intestinal flora in human health, making intestinal microorganisms a key force in changing the future of health.
Leeuwenhoek was founded in August 2011 as a start-up company derived from the technology transfer of National Taiwan University. We focus on providing microbial polysomics technology services and are committed to developing innovative services and products that promote metabolic health through intestinal flora regulation.
We are scientifically research-based and are committed to expanding innovative applications of intestinal flora in human health, making intestinal microorganisms a key force in changing the future of health.

Three major technical blocks

Leeuwenhoek has the world's largest library of Akkermansia strains for next-generation probiotics
The world's third largest intestinal bacterial metabolome database and a self-developed next-generation synbiotic technology platform
Establish our leading position in intestinal health research and application.
Leeuwenhoek has the world's largest resource library of next-generation probiotic Akkermansia strains, the world's third largest intestinal bacterial metabolite database, and an independently developed next-generation synbiotic technology platform, which establishes our leading position in intestinal health research and application.

Rediscover Microbiology

Leeuwenhoek connects the final piece of the puzzle
Unlocking breakthroughs in the future of biotechnology
Cumulative Samples Analyzed in Taiwan from Dec 2024 to Present
Microscope 2

Academic and Research Institutions

0 +

Medical Institutions

0 +

Industry Clients

0 +
Based on scientific evidence and supported by experimental results
Your best partner in research

Latest News & Events

Insights & Highlights